Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
**What it means:** The MUSC team evaluated multiple approaches (gene therapy, micro-RNA therapeutics) and chose the RNA-based approach because it "offered several advantages." These likely include: - ...
MicroRNAs are tiny RNA molecules (about 22 nucleotides long) that regulate gene expression after transcription. They can bind to mRNA molecules and either block them from being translated into protein...
**What it means:** In the cell, microRNAs normally act like "volume knobs" — they bind to messenger RNA molecules and turn down (or off) the amount of protein produced. The MUSC team's approach uses s...
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
**What it means:** Theripio Innovations is the **startup company** founded by Dr. Christopher Cowan at MUSC to commercialize the MEF2C RNA therapeutic platform. In drug development, when academic rese...
**What it means:** RNA is the molecular "messenger" that carries instructions from DNA to the protein-making machinery of the cell. RNA therapeutics work by modifying this messaging process. For MHS, ...
**What it means:** Epigenetics is the study of changes in gene **activity** that don't involve changes to the DNA sequence itself. Think of your DNA as a piano — the keys (genes) are always there. Epi...
**What it means:** Imagine your DNA is a library of instruction manuals (genes). A transcription factor is like a **foreman** who walks through the library, finds the right manual, and tells the worke...